Latest News
CD rates are still elevated in 2026. Here's the simplest strategy to lock in yield without getting stuck if rates fall.
Via The Motley Fool · February 27, 2026
This company is helping resolve a key strategic rare earth supply chain problem for the U.S.
Via The Motley Fool · February 27, 2026
Shares of Micron are up more than 250% since the summer.
Via The Motley Fool · February 27, 2026
Microsoft and Meta Platforms are trading at attractive levels.
Via The Motley Fool · February 27, 2026
Via Talk Markets · February 27, 2026
Frontdoor Inc. (NASDAQ:FTDR) Presents a Compelling Value Case with Strong Fundamentalschartmill.com
Via Chartmill · February 27, 2026
Welltower is a much healthier REIT.
Via The Motley Fool · February 27, 2026
Here's what the benchmarks look like for ideal retirement savings at age 50 -- and what to do if you're behind.
Via The Motley Fool · February 27, 2026
If you're going to make a change, do so carefully.
Via The Motley Fool · February 27, 2026
A lot of people keep too much cash in their checking account. Here's the simple rule of thumb that protects you from overdrafts without costing you interest.
Via The Motley Fool · February 27, 2026
Hamilton Insurance Group Ltd. (NYSE:HG) Shows Strong Momentum and Technical Breakout Potentialchartmill.com
Via Chartmill · February 27, 2026
Via Talk Markets · February 27, 2026
Apple needs more revenue from Wearables, and new artificial intelligence (AI) smart devices could build positive buzz for this tech stock.
Via The Motley Fool · February 27, 2026
Oklo is a leading SMR company but it has one glaring issue not faced by BWX Technologies.
Via The Motley Fool · February 27, 2026
If you manage the household finances and die unexpectedly, your spouse could be left scrambling. Here's a practical roadmap to help them take over without the stress.
Via The Motley Fool · February 27, 2026
Most investors end up less than happy with their decision to utilize them.
Via The Motley Fool · February 27, 2026
Via Talk Markets · February 27, 2026
Alnylam Pharmaceuticals Inc (NASDAQ:ALNY): A GARP Case Study in Affordable Growthchartmill.com
Via Chartmill · February 27, 2026
KORE stated that Searchlight and Abry will acquire all shares of the company’s issued and outstanding common stock that they currently don’t own in an all-cash transaction valued at nearly $726 million.
Via Stocktwits · February 27, 2026
High-yield savings rates won't stay high forever. Here's why I'm starting to lock some of mine into CDs.
Via The Motley Fool · February 27, 2026

The massive spending on AI infrastructure this year is likely to send these stocks higher.
Via The Motley Fool · February 27, 2026
The company priced a $48 million registered direct offering to a single institutional investor.
Via Stocktwits · February 27, 2026
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) announced better-than-expected revenue in Q4 CY2025, with sales up 29.6% year on year to $247.1 million. The company’s full-year revenue guidance of $1.09 billion at the midpoint came in 4.8% above analysts’ estimates. Its non-GAAP profit of $2.33 per share was 17.9% above analysts’ consensus estimates.
Via StockStory · February 27, 2026